Eqis Capital Management, Inc. Teva Pharmaceutical Industries LTD Transaction History
Eqis Capital Management, Inc.
- $1.17 Billion
- Q2 2024
A detailed history of Eqis Capital Management, Inc. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 34,650 shares of TEVA stock, worth $601,870. This represents 0.05% of its overall portfolio holdings.
Number of Shares
34,650Holding current value
$601,870% of portfolio
0.05%Shares
13 transactions
Others Institutions Holding TEVA
# of Institutions
604Shares Held
567MCall Options Held
25.2MPut Options Held
5.08M-
Black Rock Inc. New York, NY43MShares$747 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.3MShares$631 Million41.14% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L332.3MShares$562 Million5.5% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.1MShares$506 Million7.9% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$501 Million3.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19.3B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...